Difference in the prevalence of gestational diabetes mellitus according to gestational age at 75-g oral glucose tolerance test in Japan: The Japan Assessment of Gestational Diabetes Mellitus Screening trial

J Diabetes Investig. 2019 Nov;10(6):1576-1585. doi: 10.1111/jdi.13044. Epub 2019 Apr 19.

Abstract

Aims/introduction: To evaluate the differences in the results of 75-g oral glucose tolerance tests (OGTTs) according to gestational age in Japan.

Materials and methods: In this prospective cohort study, 2,578 pregnant women were divided into three categories based on their gestational age during the 75-g OGTT: <14 weeks' gestation, 14-23 weeks' gestation and 24-32 weeks' gestation. The association between gestational age and the results of the 75-g OGTT were evaluated using multivariable analysis.

Results: Early gestational age was associated with high fasting plasma glucose levels at the time of the 75-g OGTT, and low corresponding 1-h and 2-h plasma glucose levels. Compared with women with a gestational age of 24-32 weeks, women who had undergone the 75-g OGTT at <14 weeks' gestation had significantly higher odds of gestational diabetes mellitus diagnosis based on the currently used criteria in Japan (adjusted odds ratio 1.42, 95% confidence interval 1.07-1.90).

Conclusions: The results of the 75-g OGTT varied by gestational age. The use of the same 75-g OGTT cut-off values for the diagnosis of gestational diabetes mellitus, regardless of gestational age, might lead to increases in the prevalence of gestational diabetes mellitus diagnosis in Japan.

Keywords: 75-g Oral glucose tolerance test; Gestational age; Gestational diabetes mellitus.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Biomarkers / blood*
  • Blood Glucose / analysis*
  • Diabetes, Gestational / blood
  • Diabetes, Gestational / epidemiology*
  • Female
  • Follow-Up Studies
  • Gestational Age*
  • Glucose Tolerance Test / standards*
  • Humans
  • Japan / epidemiology
  • Pregnancy
  • Prevalence
  • Prognosis
  • Prospective Studies
  • Risk Assessment / standards*

Substances

  • Biomarkers
  • Blood Glucose